Staar Surgical Stock Performance
| STAA Stock | USD 17.58 0.51 2.99% |
The entity owns a Beta (Systematic Risk) of -0.29, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning STAAR Surgical are expected to decrease at a much lower rate. During the bear market, STAAR Surgical is likely to outperform the market. At this point, STAAR Surgical has a negative expected return of -0.68%. Please make sure to validate STAAR Surgical's information ratio, skewness, day typical price, as well as the relationship between the treynor ratio and daily balance of power , to decide if STAAR Surgical performance from the past will be repeated at future time.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days STAAR Surgical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 183 M | |
| Total Cashflows From Investing Activities | -59.2 M |
STAAR Surgical Relative Risk vs. Return Landscape
If you would invest 2,741 in STAAR Surgical on November 8, 2025 and sell it today you would lose (983.00) from holding STAAR Surgical or give up 35.86% of portfolio value over 90 days. STAAR Surgical is currently does not generate positive expected returns and assumes 3.1437% risk (volatility on return distribution) over the 90 days horizon. In different words, 28% of stocks are less volatile than STAAR, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
STAAR Surgical Target Price Odds to finish over Current Price
The tendency of STAAR Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 17.58 | 90 days | 17.58 | about 97.0 |
Based on a normal probability distribution, the odds of STAAR Surgical to move above the current price in 90 days from now is about 97.0 (This STAAR Surgical probability density function shows the probability of STAAR Stock to fall within a particular range of prices over 90 days) .
STAAR Surgical Price Density |
| Price |
Predictive Modules for STAAR Surgical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as STAAR Surgical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.STAAR Surgical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. STAAR Surgical is not an exception. The market had few large corrections towards the STAAR Surgical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold STAAR Surgical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of STAAR Surgical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.66 | |
β | Beta against Dow Jones | -0.29 | |
σ | Overall volatility | 2.98 | |
Ir | Information ratio | -0.24 |
STAAR Surgical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of STAAR Surgical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for STAAR Surgical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| STAAR Surgical generated a negative expected return over the last 90 days | |
| STAAR Surgical has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 313.9 M. Net Loss for the year was (20.21 M) with profit before overhead, payroll, taxes, and interest of 170.33 M. | |
| STAAR Surgical has a strong financial position based on the latest SEC filings | |
| Over 100.0% of the company shares are owned by institutional investors |
STAAR Surgical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of STAAR Stock often depends not only on the future outlook of the current and potential STAAR Surgical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. STAAR Surgical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 49.1 M | |
| Cash And Short Term Investments | 230.5 M |
STAAR Surgical Fundamentals Growth
STAAR Stock prices reflect investors' perceptions of the future prospects and financial health of STAAR Surgical, and STAAR Surgical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on STAAR Stock performance.
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.0788 | ||||
| Profit Margin | (0.42) % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 737.02 M | ||||
| Shares Outstanding | 49.37 M | ||||
| Price To Earning | 460.83 X | ||||
| Price To Book | 2.53 X | ||||
| Price To Sales | 3.75 X | ||||
| Revenue | 313.9 M | ||||
| EBITDA | (5.72 M) | ||||
| Cash And Equivalents | 202.49 M | ||||
| Cash Per Share | 4.22 X | ||||
| Total Debt | 38.74 M | ||||
| Debt To Equity | 0.10 % | ||||
| Book Value Per Share | 7.17 X | ||||
| Cash Flow From Operations | 15.72 M | ||||
| Earnings Per Share | (1.89) X | ||||
| Total Asset | 509.52 M | ||||
| Retained Earnings | (67.58 M) | ||||
| Current Asset | 49.07 M | ||||
| Current Liabilities | 17.89 M | ||||
About STAAR Surgical Performance
By analyzing STAAR Surgical's fundamental ratios, stakeholders can gain valuable insights into STAAR Surgical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if STAAR Surgical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if STAAR Surgical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. Staar Surgical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 692 people.Things to note about STAAR Surgical performance evaluation
Checking the ongoing alerts about STAAR Surgical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for STAAR Surgical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| STAAR Surgical generated a negative expected return over the last 90 days | |
| STAAR Surgical has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 313.9 M. Net Loss for the year was (20.21 M) with profit before overhead, payroll, taxes, and interest of 170.33 M. | |
| STAAR Surgical has a strong financial position based on the latest SEC filings | |
| Over 100.0% of the company shares are owned by institutional investors |
- Analyzing STAAR Surgical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether STAAR Surgical's stock is overvalued or undervalued compared to its peers.
- Examining STAAR Surgical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating STAAR Surgical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of STAAR Surgical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of STAAR Surgical's stock. These opinions can provide insight into STAAR Surgical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for STAAR Stock analysis
When running STAAR Surgical's price analysis, check to measure STAAR Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STAAR Surgical is operating at the current time. Most of STAAR Surgical's value examination focuses on studying past and present price action to predict the probability of STAAR Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STAAR Surgical's price. Additionally, you may evaluate how the addition of STAAR Surgical to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |